Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 1
2001 1
2003 2
2005 1
2006 1
2010 1
2011 2
2013 1
2014 1
2016 1
2017 2
2018 5
2019 4
2020 4
2021 4
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Emamekhoo H, Olsen MR, Carthon BC, Drakaki A, Percent IJ, Molina AM, Cho DC, Bendell JC, Gordan LN, Rezazadeh Kalebasty A, George DJ, Hutson TE, Arrowsmith ER, Zhang J, Zoco J, Johansen JL, Leung DK, Tykodi SS. Emamekhoo H, et al. Among authors: gordan ln. Cancer. 2022 Mar 1;128(5):966-974. doi: 10.1002/cncr.34016. Epub 2021 Nov 16. Cancer. 2022. PMID: 34784056 Free PMC article. Clinical Trial.
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial.
Tykodi SS, Gordan LN, Alter RS, Arrowsmith E, Harrison MR, Percent I, Singal R, Van Veldhuizen P, George DJ, Hutson T, Zhang J, Zoco J, Johansen JL, Rezazadeh Kalebasty A. Tykodi SS, et al. Among authors: gordan ln. J Immunother Cancer. 2022 Feb;10(2):e003844. doi: 10.1136/jitc-2021-003844. J Immunother Cancer. 2022. PMID: 35210307 Free PMC article. Clinical Trial.
Survivorship care throughout the cancer journey.
Champlain D, Gordan L. Champlain D, et al. Among authors: gordan l. Am J Manag Care. 2018 Aug;24(10 Spec No.):SP438-SP439. Am J Manag Care. 2018. PMID: 30260615 Free article. No abstract available.
Considerations to increase rates of breast cancer screening across populations.
Patt D, Gordan L, Patel K, Okon T, Ferreyros N, Markward N, Sullivan M, Burnett B, Getachew B, Harris C. Patt D, et al. Among authors: gordan l. Am J Manag Care. 2022 Apr;28(3 Spec. No.):SP136-SP138. doi: 10.37765/ajmc.2022.88855. Epub 2022 Mar 14. Am J Manag Care. 2022. PMID: 35285592 Free article.
New Enhancing Oncology Model builds on knowledge from the OCM.
Khrystolubova N, Bailey R, Orr R, Gordan L, Auger T. Khrystolubova N, et al. Among authors: gordan l. Am J Manag Care. 2022 Aug;28(6 Spec No.):SP405-SP406. doi: 10.37765/ajmc.2022.89229. Am J Manag Care. 2022. PMID: 36049232 Free article. No abstract available.
36 results